• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TS-HDS 和 FGFR3 抗体在小纤维神经病和自主神经病变中的作用。

TS-HDS and FGFR3 antibodies in small fiber neuropathy and Dysautonomia.

机构信息

Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Muscle Nerve. 2021 Jul;64(1):70-76. doi: 10.1002/mus.27245. Epub 2021 Apr 15.

DOI:10.1002/mus.27245
PMID:33792960
Abstract

INTRODUCTION

The specificity of trisulfated heparin disaccharide/fibroblast growth factor receptor 3 (TS-HDS/FGFR3) antibodies in the diagnosis of autoimmune small fiber neuropathy (SFN) is unclear.

METHODS

This was a retrospective study of patients evaluated for SFN and dysautonomia in the Brigham and Women's Faulkner Hospital Autonomic Laboratory in 2019-2020. Associations were assessed between TS-HDS/FGFR3 antibodies and SFN markers, including epidermal nerve fiber density (ENFD), sweat gland nerve fiber density (SGNFD), and autonomic dysfunction assessed by Valsalva maneuver, deep breathing, sudomotor, and tilt testing.

RESULTS

Of 322 patients; 28% had elevated anti-TS-HDS, 17% had elevated anti-FGFR3, 96% had autonomic dysfunction, 71% had abnormal ENFD, and 49% had abnormal SGNFD. TS-HDS/FGFR3 antibodies were present in patients with autonomic dysfunction irrespective of whether they had normal or abnormal skin biopsies unless ENFD/SGNFD were combined for anti-FGFR3 seropositivity.

DISCUSSION

TS-HDS/FGFR3 antibodies are present in patients with evidence of autonomic dysfunction. Further studies are needed to document the clinical value of these antibodies in assessment of immune mediated dysautonomia.

摘要

简介

三硫酸化肝素二糖/成纤维细胞生长因子受体 3(TS-HDS/FGFR3)抗体在自身免疫性小纤维神经病(SFN)诊断中的特异性尚不清楚。

方法

这是 2019-2020 年在布莱根妇女医院福克纳医院自主实验室评估 SFN 和自主神经功能障碍患者的回顾性研究。评估了 TS-HDS/FGFR3 抗体与 SFN 标志物(包括表皮神经纤维密度(ENFD)、汗腺神经纤维密度(SGNFD)和瓦尔萨尔瓦动作、深呼吸、出汗和倾斜试验评估的自主功能障碍)之间的相关性。

结果

在 322 名患者中;28%的患者抗 TS-HDS 升高,17%的患者抗 FGFR3 升高,96%的患者自主功能障碍,71%的患者 ENFD 异常,49%的患者 SGNFD 异常。无论皮肤活检是否正常,只要将 ENFD/SGNFD 结合起来用于抗 FGFR3 阳性,有自主神经功能障碍的患者都存在 TS-HDS/FGFR3 抗体。

讨论

有自主神经功能障碍证据的患者存在 TS-HDS/FGFR3 抗体。需要进一步研究来证明这些抗体在评估免疫介导的自主神经功能障碍中的临床价值。

相似文献

1
TS-HDS and FGFR3 antibodies in small fiber neuropathy and Dysautonomia.TS-HDS 和 FGFR3 抗体在小纤维神经病和自主神经病变中的作用。
Muscle Nerve. 2021 Jul;64(1):70-76. doi: 10.1002/mus.27245. Epub 2021 Apr 15.
2
Effectiveness of IVIG on Non-Length-Dependent Skin Biopsies in Small Fiber Neuropathy With Plexin D1, Trisulfated Heparin Disaccharide, and Fibroblast Growth Factor Receptor 3 Autoantibodies.免疫球蛋白静脉注射治疗小纤维神经病伴 Plexin D1、三硫酸肝素二糖和成纤维细胞生长因子受体 3 自身抗体的非长度依赖性皮肤活检的疗效。
J Clin Neuromuscul Dis. 2024 Jun 1;25(4):184-196. doi: 10.1097/CND.0000000000000485.
3
Current Diagnosis and Treatment of Painful Small Fiber Neuropathy.疼痛性小纤维神经病的当前诊断与治疗。
Curr Neurol Neurosci Rep. 2019 Nov 26;19(12):103. doi: 10.1007/s11910-019-1020-1.
4
Clinical Features and Treatment Response in Immune-Mediated Small Fiber Neuropathy with Trisulfated Heparin Disaccharide or Fibroblast Growth Factor Receptor 3 Antibodies.免疫介导的小纤维神经病中三硫酸肝素二糖或成纤维细胞生长因子受体 3 抗体的临床特征和治疗反应。
J Clin Neuromuscul Dis. 2021 Jun 1;22(4):192-199. doi: 10.1097/CND.0000000000000355.
5
Immune-Mediated Small Fiber Neuropathy With Trisulfated Heparin Disaccharide, Fibroblast Growth Factor Receptor 3, or Plexin D1 Antibodies: Presentation and Treatment With Intravenous Immunoglobulin.免疫介导的小纤维神经病伴三硫酸肝素二糖、成纤维细胞生长因子受体 3 或神经丛蛋白 D1 抗体:静脉注射免疫球蛋白的表现和治疗。
J Clin Neuromuscul Dis. 2022 Sep 1;24(1):26-37. doi: 10.1097/CND.0000000000000423.
6
Comparing FGFR-3 and TS-HDS Seropositive Small Fiber Neuropathy: Unique Patient Features, Symptoms, Laboratory, and Nerve Conduction Study Findings.比较 FGFR-3 和 TS-HDS 阳性小纤维神经病:独特的患者特征、症状、实验室和神经传导研究结果。
J Clin Neuromuscul Dis. 2024 Jun 1;25(4):171-177. doi: 10.1097/CND.0000000000000478.
7
Cryptogenic small-fiber neuropathies: Serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor-3.不明原因的小纤维神经病:血清自身抗体与三硫酸化肝素二糖和成纤维细胞生长因子受体-3结合。
Muscle Nerve. 2020 Apr;61(4):512-515. doi: 10.1002/mus.26748. Epub 2019 Nov 6.
8
A double-blind placebo-controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS-HDS and FGFR-3 autoantibodies.一项针对与 TS-HDS 和 FGFR-3 自身抗体相关的小纤维神经病的免疫球蛋白的双盲安慰剂对照初步研究。
Muscle Nerve. 2023 May;67(5):363-370. doi: 10.1002/mus.27745. Epub 2022 Nov 29.
9
Prevalence of Axonal Sensory Neuropathy With IgM Binding to Trisulfated Heparin Disaccharide in Patients With Fibromyalgia.纤维肌痛患者中IgM与三硫酸化肝素二糖结合的轴索性感觉神经病变的患病率
J Clin Neuromuscul Dis. 2019 Mar;20(3):103-110. doi: 10.1097/CND.0000000000000236.
10
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience.TS-HDS 自身抗体:来自真实世界三级护理中心经验的临床特征和应用。
J Neurol. 2023 Sep;270(9):4523-4528. doi: 10.1007/s00415-023-11798-9. Epub 2023 Jun 9.

引用本文的文献

1
Small fiber neuropathy: expanding diagnosis with unsettled etiology.小纤维神经病变:病因未明情况下诊断范围的扩大
Curr Opin Neurol. 2025 Oct 1;38(5):485-495. doi: 10.1097/WCO.0000000000001418. Epub 2025 Aug 20.
2
Post-COVID-19 Small Fiber Neuropathy as a New Emerging Quality of Life-Threatening Disease: A Systematic Review.新冠后小纤维神经病变作为一种新出现的危及生活质量的疾病:一项系统综述
Microorganisms. 2025 Feb 2;13(2):328. doi: 10.3390/microorganisms13020328.
3
Small fiber neuropathy with dysautonomia and positive GPCR and FGFR-3 antibodies after the first BNT162b2 dose.
首次接种BNT162b2疫苗后出现伴有自主神经功能障碍以及GPCR和FGFR-3抗体阳性的小纤维神经病变。
Clinics (Sao Paulo). 2025 Jan 27;80:100557. doi: 10.1016/j.clinsp.2024.100557. eCollection 2025.
4
The Diagnostic Journey of Dysautonomia Patients: Insights from a Patient-Reported Outcome Study.自主神经功能障碍患者的诊断历程:一项患者报告结局研究的见解
J Patient Exp. 2025 Jan 21;12:23743735251314651. doi: 10.1177/23743735251314651. eCollection 2025.
5
Autoantigens of Small Nerve Fibers and Human Coronavirus Antigens: Is There a Possibility for Molecular Mimicry?小纤维神经自身抗原与人类冠状病毒抗原:是否存在分子模拟的可能性?
Curr Microbiol. 2024 Sep 19;81(11):366. doi: 10.1007/s00284-024-03885-5.
6
Case-Control Study of Individuals With Small Fiber Neuropathy After COVID-19.新冠后小纤维神经病个体的病例对照研究。
Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200244. doi: 10.1212/NXI.0000000000200244. Epub 2024 Apr 17.
7
Post-COVID Small Fiber Neuropathy, Implications of Innate Immunity, and Challenges on IVIG Therapy.新冠后小纤维神经病变、固有免疫的影响及静脉注射免疫球蛋白治疗面临的挑战
Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200248. doi: 10.1212/NXI.0000000000200248. Epub 2024 Apr 17.
8
A role for pathogenic autoantibodies in small fiber neuropathy?致病性自身抗体在小纤维神经病变中起作用吗?
Front Mol Neurosci. 2023 Sep 20;16:1254854. doi: 10.3389/fnmol.2023.1254854. eCollection 2023.
9
Neurological Disorders following COVID-19 Vaccination.新冠疫苗接种后的神经系统疾病
Vaccines (Basel). 2023 Jun 19;11(6):1114. doi: 10.3390/vaccines11061114.
10
Small Fiber Neuropathy Triggered by COVID-19 Vaccination: Association with FGFR3 Autoantibodies and Improvement during Intravenous Immunoglobulin Treatment.新冠疫苗接种引发的小纤维神经病变:与FGFR3自身抗体的关联及静脉注射免疫球蛋白治疗期间的改善情况
Case Rep Neurol. 2023 Jan 27;15(1):6-10. doi: 10.1159/000528566. eCollection 2023 Jan-Dec.